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Background: Serum γ-glutamyltransferase (GGT) and uric acid (UA) levels are elevated in patients with diabetes or
cardiovascular disease. Prediabetes, characterized by impaired glucose tolerance, is an important risk factor for overt
diabetes as well as cardiovascular disease. Therefore, the aim of this study was to explore the relationship between
GGT, UA and prediabetes in a Chinese population, and provide a scientific basis for the early prevention and
treatment of diabetes.
Methods: We performed a cross-sectional population-based study in a cohort of 2694 subjects (1211 men and
1483 women, aged 35–86 years). Questionnaires and physical examinations were performed using standardized
procedures. Fasting blood was collected to measure glucose and other biochemical parameters. The subjects were
divided into two groups with either normal fasting glucose (NFG) or impaired fasting glucose (IFG), according to
international diagnostic criteria. Logistic regression analysis was performed to estimate odds ratios (OR) and 95%
confidence intervals.
Results: Compared with the NFG group, the IFG group had significantly higher blood pressure but lower high-
density lipoprotein–cholesterol in women. Body mass index, waist circumference, triglyceride, glucose, GGT, and UA
levels were significantly higher in males and females in the IFG group than those in the NFG group. Logistic
regression analysis revealed that the OR for prediabetes increased with increasing serum GGT quartiles and UA
quartiles. GGT and UA were positively associated with prediabetes in men and women, independent of age,
ethnicity, smoking, alcohol consumption, blood pressure, physical labor, and other confounders.
Conclusions: We found that serum GGT and UA levels were positively associated with prediabetes in men and
women living in areas inhabited by Chinese ethnic minorities. As elevated GGT and UA levels were associated with
significantly increased risk of prediabetes, they may be used as sensitive biological markers of prediabetes.
Keywords: γ-Glutamyltransferase, Uric acid, Prediabetes, Impaired fasting glucoseBackground
Serum γ-glutamyltransferase (GGT), which is mainly de-
rived from the liver, is a sensitive marker of liver cell dam-
age and oxidative stress. Uric acid (UA) is the final
oxidation product of human purine metabolism and is
used clinically as a marker of inflammation and metabolic* Correspondence: lingqiubj@yahoo.com.cn
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reproduction in any medium, provided the ordisease. Recent studies have revealed that elevated
serum GGT levels and hyperuricemia are closely asso-
ciated with diabetes and cardiovascular disease [1-3].
Therefore, recent studies that examined the associa-
tions of serum GGT and UA levels with clinically de-
fined blood glucose categories corresponding to early
stages of diabetes have received considerable attention
in terms of diabetes prevention.
Prediabetes is an important risk factor for the develop-
ment of overt diabetes as well as cardiovascular disease
[4,5], and is defined as impaired fasting glucose (IFG) and/. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ciation defines IFG as fasting serum glucose concentrations
of 5.6–6.9 mmol/L (100–125 mg/dL) and IGT as serum
glucose concentrations of 7.8–11.1 mmol/L (140–199 mg/
dL) at 2 h after a 75 g oral glucose load [6]. IFG is associ-
ated with insulin resistance and with a greater conversion
from prediabetes to overt diabetes (approximately 24%
within 3 years) compared with IGT [7]. Nationwide sur-
veys conducted in the United States revealed that prediabe-
tes was very prevalent among adolescents [8,9]. In a recent
population-based study involving >45,000 people in China,
the prevalence of prediabetes was 15.5% [10].
In our previous study, we observed higher GGT and UA
levels in subjects with coexisting prehypertension and pre-
diabetes, which suggests that GGT and UA are associated
with prediabetes [11]. Similarly, results of several surveys
conducted in the United States and other countries impli-
cated GGT and/or UA in the development of diabetes
[12-15]. The associations of serum GGT and UA levels
with plasma glucose levels were reported recently among
Chinese adults in Qingdao, a coastal city of China [16,17].
However, China is a multi-ethnic country with marked re-
gional differences, and little is known about the associa-
tions of serum GGTand UA levels with prediabetes among
individuals living in areas inhabited by Chinese ethnic mi-
norities. Therefore, in this study, we enrolled a representa-
tive cohort of subjects living in Inner Mongolian
Autonomous Region using a random, multistage cluster
sampling scheme. The enrolled subjects completed a ques-
tionnaire, and underwent physical examinations and bio-
chemical tests. We examined the associations of GGT and
UA with IFG as a marker of prediabetes, and determined
the potential risk factors for prediabetes in this population.
Methods
Study population
A population-based, cross-sectional survey of the Chinese
Physiological Constant and Health Condition was
conducted between 2009 and 2010. A representative
sample of the general Chinese population, aged 35–
86 years, in two urban and two rural areas of the Inner
Mongolian Autonomous Region was identified using a ran-
dom, multistage cluster-sampling method. Written in-
formed consent was obtained from each participant before
data collection. The protocol was approved by the Institu-
tional Review Board of the Institute of Basic Medical Sci-
ences, Chinese Academy of Medical Sciences. Trained
medical personnel collected information on risk factors via
questionnaires, and obtaining anthropometric measure-
ments and blood samples for biochemical assessments.
Exclusion criteria
Participants with known systemic diseases, including
diabetes mellitus, hypertension, cardiovascular disease,renal disease, gastrointestinal disease, pulmonary disease,
or cancer were excluded. Participants taking any drugs
known to affect carbohydrate or lipid metabolism were
also excluded. After applying these criteria, 2694 partici-
pants were eligible for this study and were analyzed.
Data collection
All of the participants completed a standard question-
naire, which included demographic characteristics (e.g.,
age, sex, and ethnicity), physical condition, lifestyle habits
and customs (e.g., smoking status, alcohol consumption,
and manual labor), past medical history, and lifestyle risk
factors. Manual labor was classified as light physical (i.e.,
students and white-collar workers), moderate physical
(i.e., staff and teachers), and heavy physical (i.e. farmers
and blue-collar workers). Body weight was measured to
the nearest 0.1 kg using a calibrated beam scale and height
was measured barefoot three times using a wall-mounted
stadiometer (Seca, Hamburg, Germany) to the nearest
0.1 cm. Body mass index (BMI) was calculated as body
weight (in kilograms) divided by height (in meters
squared). Waist circumference (WC) was measured mid-
way between the lower rib margin and the iliac crest at
the end of a gentle expiration. Blood pressure (BP) was
measured using OMRON HEM-7000 electronic sphyg-
momanometer (OMRON HealthCare, Kyoto, Japan) after
the participant had rested for ≥10 min. The participant’s
arm was placed at the level of the heart and the mean of
three BP measurements was used.
Laboratory measurements
All procedures were performed after a 12-h overnight
fast. Blood was drawn from the antecubital vein of the
right arm. Serum GGT, UA, fasting blood glucose (FBG),
and other biochemical tests were assayed with an Olym-
pus AU2700 Automatic Biochemical Analyzer (Olympus,
Tokyo, Japan). The participants were classified according
to FBG as having normal FBG (<5.6 mmol/L; NFG) or
IFG (FBG 5.6–6.9 mmol/L) according to the American
Diabetes Association criteria [6]. Lipid profiles, including
total cholesterol (TC), triglycerides (TG), high-density
lipoprotein–cholesterol (HDL-C), and low-density lipo-
protein–cholesterol (LDL-C) were also measured. The
biochemical laboratories participating in the survey ad-
hered to the same internal quality control program that
was standardized by Peking Union Medical College Hos-
pital. The laboratory reference ranges for GGT and UA
are 0–50 U/L and 104–444 U/L, respectively.
Statistical analysis
Data were analyzed using SPSS 13.0 software (SPSS Inc.,
Chicago, IL, USA). Normally distributed continuous vari-
ables are presented as means ± standard deviation (SD). All
categorical data are presented as percentages. Comparisons
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made using an analysis of covariance F-test. GGT, TG, as-
partate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), and creatine kinase
(CK) levels showed skewed distributions and are presented
as medians (interquartile range). These variables were com-
pared between groups using the Wilcoxon rank sum test.
Correlation analysis and linear regression were used to de-
termine the associations between biochemical indicators
and fasting blood glucose. The participants were then di-
vided into quartiles of sex-specific serum GGT and UA
levels. Multivariate logistic regression was used to calculate
the odds ratio (OR) and 95% confidence intervals (CI), as
well as the corresponding P-values and effects of eachTable 1 Baseline characteristics of participants according to F
Male
NFG IFG
n (%) 878 (72.5%) 333 (27.5%)
Age (years) 52.97 ± 11.68 53.39 ± 11.6
Ethnic group (%)
Han 624 (71.1%) 266 (79.9%)
Mongolian 235 (26.8%) 56 (16.8%)
Other 19 (2.1%) 11 (3.3%)
Smoking (%) 387 (44.1%) 155 (46.5%)
Drinking (%) 449 (51.1%) 188 (56.5%)
Manual labor (%)
Light 528 (60.1%) 187 (56.2%)
Moderate 140 (15.9%) 64 (19.2%)
Heavy 123 (14.0%) 45 (13.5%)
BMI (kg/m2) 25.2 ± 3.6 26.1 ± 3.6*
WC (cm) 88.2 ± 10.0 90.0 ± 9.5*
SBP (mmHg) 129.1 ± 15.8 130.8 ± 14.6
DBP (mmHg) 83.2 ± 10.6 84.4 ± 10.6
TC (mmol/L) 5.16 ± 1.05 5.37 ± 1.07*
TG (mmol/L) 1.50 (1.08–2.32) 1.98 (1.31–2
HDL-C (mmol/L) 1.32 ± 0.29 1.29 ± 0.27
LDL-C (mmol/L) 2.85 ± 0.85 2.93 ± 0.87
GLU (mmol/L) 5.03 ± 0.38 6.03 ± 0.38*
AST (U/L) 24.5 (20.8–29.8) 24.7 (21.2–3
ALT (U/L) 24.1 (17.9–34.3) 26.7 (19.0–4
GGT (U/L) 32.4 (21.5–32.4) 40.3 (26.4–6
ALP (U/L) 81.7 (69.2–94.5) 81.7 (68.0–9
CK (U/L) 98.9 (76.2–135.1) 103.0 (82.6–
UA (μmmol/L) 347.1 ± 78.8 365.6 ± 83.3
1 Abbreviations: FBG, Fasting blood glucose; NFG, Normal fasting glucose; IFG, Impa
Systolic blood pressure; DBP, Diastolic blood pressure; TC, Total cholesterol; TG, Trig
lipoprotein cholesterol; GLU, Glucose; AST, Aspartate aminotransferase; ALT, Alanine
Creatine kinase; UA, Uric acid.
2 Data are presented as n (%), mean ± standard deviation (SD); TG, AST, ALT, GGT, A
3 *P < 0.05 for IFG vs. NFG in the same sex.categorical variable. All statistical tests were two-tailed, and
considered significant at P < 0.05.
Results
Clinical characteristics of the IFG and NFG groups
stratified by sex
As shown in Table 1, there was no significant difference
in mean age between the IFG and NFG groups for men,
but the IFG group was older than the NFG group for
women. The prevalence of IFG was higher in men
(27.5%) than in women (17.5%). Among men, the pro-
portions of smokers and drinker were greater in the IGF
group than in the NFG group. Among women, the IFG
group had significantly higher systolic and diastolicBG levels
Female
NFG IFG
1224 (82.5%) 259 (17.5%)
0 50.62 ± 10.20 54.39 ± 10.87*
801 (65.4%) 219 (84.5%)
398 (32.5%) 35 (13.5%)
26 (2.1%) 5 (2%)
76 (6.2%) 16 (6.2%)
64 (5.2%) 14 (5.4%)
771 (63.0%) 174 (67.2%)
27 (22.1%) 45 (17.4%)
77 (6.3%) 17 (6.6%)
24.8 ± 3.5 25.7 ± 3.4*
81.1 ± 9.4 84.8 ± 9.0*
123.3 ± 15.5 127.5 ± 16.3*
79.8 ± 9.6 81.6 ± 9.9*
5.16 ± 0.99 5.27 ± 1.08
.95)* 1.32 (1.00–1.79) 1.72 (1.14–2.50)*
1.44 ± 0.29 1.37 ± 0.29*
2.80 ± 0.81 2.86 ± 0.84
4.98 ± 0.34 6.00 ± 0.33*
0.1) 22.1 (18.9–26.1) 23.9 (20.1–28.2)
0.0) 17.5 (13.6–24.0) 21.5 (15.8–29.7)*
3.8)* 19.1 (14.0–28.2) 24.2 (17.3–39.4)*
5.1) 76.3 (62.2–97.2) 84.0 (68.0–100.1)*
139.1)* 75.4 (60.0–100.0) 80.7 (61.5–108.2)*
* 262.1 ± 64.6 297.5 ± 69.5*
ired fasting glucose; BMI, Body mass index; WC, Waist circumference; SBP,
lyceride; HDL-C, High density lipoprotein cholesterol; LDL-C, Low density
aminotransferase; GGT, γ-Glutamyltransferase; ALP, Alkaline phosphatase; CK,
LP, and CK were reported as medians (interquartile range).
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the NFG group (P < 0.05). Regardless of sex, the preva-
lence of prediabetes was higher in Han than in Mongolian
participants. BMI, WC, TG, GLU, GGT, CK, and UA were
significantly greater in the IFG group than in the NFG
group (P < 0.05).
Correlations between liver enzymes, UA, and FBG levels
We next explored the correlations of GGT, ALP, CK and
UA with FBG levels using correlation and linear regres-
sion analyses (Table 2). Because of their skewed distribu-
tions, serum GGT, ALP, and CK were log-transformed
before the analyses. The results showed that GGT and UA
levels were significantly and positively associated with
FBG levels in both sexes. ALP and CK were associated
with FBG in females, and the association disappeared after
adjusting for age and other factors using logistic regres-
sion analysis. In men, the standardized coefficients of
GGT and UA were 0.144 and 0.133, with R2 values of 2.1%
and 1.8%, respectively. In women, the standardized coeffi-
cients of GGT and UA were 0.170 and 0.220, with R2
values of 2.9% and 4.8%, respectively. These coefficients
and R2 values indicate that FBG levels were also
influenced by other factors. Therefore we need to exclude
confounding factors (such as age and sex) to further con-
firm the correlations.
Non-conditional logistic regression analysis of the
associations of serum GGT and UA quartiles with IFG
Table 3 shows sex-specific associations of increasing
GGT and UA levels with IFG. In these analyses, IFG (no
= 0, yes = 1) was used as the dependent variable, and
quartiles of GGT and UA levels were included as inde-
pendent variables and analyzed in three risk models. TheTable 2 Correlations between GGT, ALP, CK, and UA
levels and FBG levels
FBG
Standard β coefficient R2 P values
Males (n = 1211)
GGT 0.144 0.021 < 0.001
ALP 0.008 0.000 0.772
CK 0.036 0.001 0.215
UA 0.133 0.018 < 0.001
Females (n = 1483)
GGT 0.170 0.029 < 0.001
ALP 0.110 0.012 < 0.001
CK 0.053 0.003 0.043
UA 0.220 0.048 < 0.001
1 Abbreviations: GGT, γ-Glutamyltransferase; ALP, Alkaline phosphatase; CK,
Creatine kinase; UA, Uric acid; FBG, Fasting blood glucose.
2 Correlation and linear regression analyses were used to estimate the
correlations between each variable and FBG.OR and 95% CI for IFG were calculated for each sex-
specific GGT/UA quartile, with the lowest quartile as
the reference category, in multivariate logistic regression
models. Among men and women, GGT and UA quartiles
were associated with IFG in all three models after
accounting for the effects of confounding factors. The
linear trends in these associations were also statistically
significant.
Discussion
In the present study, we compared the blood biochem-
ical parameters between participants with prediabetes
(i.e., IFG group) and those with normal glucose (i.e.,
NFG group) in a population derived from a cross-
sectional survey. Logistic regression analysis showed that
GGT and UA quartiles were positively correlated with
IFG, and the associations remained after adjusting for pos-
sible confounding factors, including age, ethnicity, smok-
ing, drinking, BMI, WC, BP, TC, TG, HDL-C, and LDL-C.
To our knowledge, this was the first study to examine the
possible associations of GGT and UA with prediabetes in
areas inhabited by Chinese ethnic minorities.
Recent cross-sectional and longitudinal studies have
found relatively independent associations between ele-
vated serum GGT levels and hypertension or diabetes
[18-21]. In the present study, among healthy men and
women in Inner Mongolia, we found that higher serum
GGT levels were positively associated with increased risk
of prediabetes, suggesting that elevated GGT levels may
provide early warning of diabetes, prompting interven-
tions to prevent diabetes. Our results are consistent with
those of previous studies examining the role of GGT in
prediabetes [14,17,22]. In our study, we found that the
OR (vs Quartile 1) for Quartile 3 was higher than that
for Quartile 2, and was slightly higher than that for
Quartile 4 (Table 3) in males, which suggests the effects
of GGT on prediabetes outcome is non-linear among
males. A similar pattern was observed for the association
between GGT and peripheral arterial disease [23]. The
possible reason for the non-linear association between
GGT and IFG in this study is as follows: In adult males,
increased GGT is often accompanied by dyslipidemia,
probably because of the adverse eating habits (for ex-
ample, people especially men from Inner Mongolia pre-
fer drinking wine and eating meat). So the OR(vs
Quartile 1) for Quartile 4 of serum GGT was slightly
lower than that for Quartile 3 in Model 3 after ruling
out lipid factors(including TC,TG,HDL-C,LDL-C),
suggesting that the effect of lipids on FBG is the most
obvious when GGT > 57 U/L.
At present, the underlying mechanisms for the in-
creased risk of IFG in individuals with elevated GGT are
unclear. In this study, BMI and WC were significantly
greater in the IFG group than in the NFG group,
Table 3 Associations of sex-specific serum GGT and UA quartiles with IFG
Subgroup IFG OR (95% CI)
(n) n (%) Model 1 Model 2 Model 3
Males
GGT
Q1 (<23 U/L) 312 59 (18.9%) 1 (ref) 1 (ref) 1 (ref)
Q2 (23–35 U/L) 305 78 (25.6%) 1.62 (1.06–2.50) 1.50 (0.97–2.31) 1.48 (0.94–2.29)
Q3 (35–57 U/L) 291 94 (32.3%) 0.91 (0.62–1.35) 2.08 (1.32–3.25) 1.99 (1.26–3.15)
Q4 (>57 U/L) 303 102 (33.7%) 1.01 (0.68–1.51) 2.14 (1.33–3.45) 1.90 (1.16–3.12)
P for trend 0.000 0.001 0.007
UA
Q1 (<296 U/L) 225 71 (31.6%) 1 (ref) 1 (ref) 1 (ref)
Q2 (296–344 U/L) 236 67 (28.4%) 0.93 (0.61–1.40) 0.84 (0.55–1.27) 0.84 (0.55–1.28)
Q3 (344–402 U/L) 221 87 (39.4%) 1.43 (0.96–2.13) 1.23 (0.82–1.85) 1.19 (0.79–1.81)
Q4 (>402 U/L) 194 107 (55.2%) 1.91 (1.28–2.84) 1.52 (1.00–2.31) 1.47 (0.96–2.25)
P for trend 0.000 0.013 0.027
Females
GGT
Q1 (<15 U/L) 409 38 (9.3%) 1 (ref) 1 (ref) 1 (ref)
Q2 (15 ~ 20 U/L) 338 49 (14.5%) 1.76 (1.06–2.94) 1.65 (0.99–2.78) 1.58 (0.94–2.67)
Q3 (20 ~ 30 U/L) 366 74 (20.2%) 2.69 (1.63–4.45) 2.44 (1.46–4.08) 2.26 (1.33–3.83)
Q4 (>30 U/L) 370 98 (26.5%) 3.52 (2.17–5.72) 3.19 (1.93–5.27) 2.86 (1.70–4.82)
P for trend 0.000 0.000 0.000
UA
Q1 (<220 U/L) 330 36 (10.9%) 1 (ref) 1 (ref) 1 (ref)
Q2 (220–262 U/L) 325 42 (12.9%) 1.16 (0.71–1.90) 1.09 (0.66–1.80) 1.08 (0.65–1.78)
Q3 (262–310 U/L) 298 71 (24.6%) 1.82 (1.15–2.90) 1.69 (1.05–2.71) 1.61 (0.99–2.61)
Q4 (>310 U/L) 262 108 (41.2%) 2.70 (1.72–4.24) 2.41 (1.52–3.84) 2.22 (1.37–3.58)
P for trend 0.000 0.000 0.000
1 Abbreviations: GGT, γ-Glutamyltransferase; UA, Uric acid; IFG, Impaired fasting glucose; OR, Odds ratio; CI, Confidence interval.
2 Multivariate logistic regression models were used to estimate the ORs and 95% CIs.
Model 1: adjusted for age, ethnicity, smoking, alcohol consumption, physical labor.
Model 2: Model 1 plus body mass index, waist circumference, systolic blood pressure, and diastolic blood pressure.
Model 3: Model 2 plus total cholesterol, triglyceride, high-density lipoprotein–cholesterol, and low-density lipoprotein–cholesterol.
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fact, serum GGT levels are closely related to body fat
[24]. Increased body fat promotes fat deposition in the
liver and induces hepatic insulin resistance, thereby trig-
ging systemic insulin resistance and the development of
IFG. Another possible pathophysiological mechanism is
that obesity is considered to be a chronic inflammatory
state, and chronic inflammation induces the release
abundant reactive oxygen species from mitochondria,
resulting in oxidative stress. This promotes an increase
in serum GGT, which has potential anti-oxidative stress
properties, but ultimately damages the liver and other
insulin-sensitive tissues [21,25].
It was suggested that UA may be a useful predictor of
type 2 diabetes in older adults with IFG [26]. Recentstudies have shown that patients with newly diagnosed
type 2 diabetes have relatively low UA levels, but UA
levels were significantly higher in people with IGT [16].
Moreover, in a 15-year follow-up study, Krishnan et al.
reported that hyperuricemia in people aged in the mid-
20s was an independent predictor of diabetes and predi-
abetes [15]. We found that women with IFG had lower
UA levels than men, possibly because estrogen could
promote urinary excretion of UA [27]. In addition, we
found that women had higher OR values for IFG among
each UA quartile than did men, after adjusting for
confounding factors. Therefore, compared with men,
women with high UA levels are at greater risk of predia-
betes. Similar results were found in a cross-sectional sur-
vey of non-diabetic adults in Taiwan [28]. A recent study
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paired glucose regulation in women than in men [29],
which further supports our conclusion.
Hyperinsulinemia is a marker of insulin resistance, a
component of metabolic syndrome [30]. The relation-
ship between UA and prediabetes may involve depos-
ition of UA in islets, which could lead to β cell damage
and functional decline, resulting in impaired glucose
handling. The pro-inflammatory and oxidative stress ef-
fects of UA may also be possible causes of impaired glu-
cose handling [31]. Several studies have suggested that
serum leptin might be a pathogenic factor responsible for
UA increase in obese patients [32-34]. Additionally, epi-
demiological studies have consistently shown that leptin is
associated with glucose metabolism in patients with predi-
abetes [35,36]. Nevertheless, the reason why women with
high UA levels are at greater risk of prediabetes than men
is unclear and requires further clarification.
Some diets can have beneficial effects on uric acid
level and fasting glucose. Dietary approaches to stop
hypertension have beneficial effects on fasting glucose
which can be related to improving some metabolic pa-
rameters linked to serum uric acid level and serum
gamma-glutamyltransferase [37].
A major strength of our study is that it is a population-
based study and the sample was a representative cohort of
subjects living in Inner Mongolian Autonomous Region.
Additionally, all data were collected using a standardized
protocol with rigorous quality control. However, the study
has several limitations to discuss. First, oral glucose tole-
rance tests were not performed, so we could not identify
participants with IGT, another characteristic of prediabe-
tes. It is possible that GGT and UA may show different
associations with IGT than with IFG. Second, as we
performed a cross-sectional survey, we could not deter-
mine causality or the temporal relationships among GGT,
UA, and prediabetes.
Conclusions
Our results demonstrate that GGT, UA, and IFG are closely
associated in individuals located in areas inhabited by
Chinese ethnic minorities. We found that higher serum
GGT and UA levels were associated with greater risk of
prediabetes, suggesting that they may serve as valuable
clinical markers of prediabetes in China. Further studies are
needed to elucidate the temporal nature of these associa-
tions, and to determine the reason why women with high
UA levels are at greater risk of prediabetes than men.
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